EXPANSIÓN: Nanobots capta casi un millón de euros en una ronda semilla
La start-up catalana Nanobots Therapeutics, una spin-off del Instituto de Bioingeniería de Catalunya, ha captado 960.000 euros de capital privado.
Samuel Sanchez
Group leader
IBEC and VHIR hold a collaboration day to promote synergies
The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.
Advances in nanobiotechnology and nanomedicine explored at the 12th International NanoBio&Med Conference
The latest developments in nanotechnology, biotechnology and medicine were presented at the NanoBio&Med 2024 International Conference, held this week at the Barcelona Science Park (PCB) from 5 to 7 November. This is an annual event designed to establish new collaborations and promote innovative projects in the scientific-industrial sector.
IBEC and BST strengthen ties with Translational Collaboration Day
IBEC and the Blood and Tissue Bank of Catalonia (BST) held a day to explore new collaborations in bioengineering and translational medicine. The meeting, held yesterday at IBEC, highlighted innovative projects, presented a joint PhD programme and strengthened the link between biomedical research and clinical applications.
Bioengineering for Emergent and Advanced Therapies at the 17th IBEC Symposium
IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.
Researcher Samuel Sánchez awarded a Leonardo Grant
IBEC researcher Samuel Sánchez has received a Leonardo Grant from the BBVA Foundation. The funding will help him take his research a step further and use organic and biocompatible materials to develop his nanorobots, which will be used as drug carriers to treat bladder cancer.
Nanorobots capable of travelling through synovial fluid to fight arthritis
Samuel Sánchez, ICREA Research Professor at the Institute for Bioengineering of Catalonia (IBEC), will lead the OrthoBots project, which focuses on the treatment of joint diseases using nanorobots. To carry out the project, Sánchez has been awarded an ERC Proof of Concept Grant, a prestigious grant from the European Research Council.
